Stockreport

Ra Pharmaceuticals Reports Second Quarter 2018 Financial Results and Announces Early Completion of Enrollment in gMG Phase 2 Program

RA PHARMACEUTICALS  (RARX) 
Last ra pharmaceuticals earnings: 11/7 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: rapharma.com/news-investors
PDF Surpassed target enrollment in Phase 2 trial of RA101495 SC for gMG Top-line data now expected around year-end 2018 Regulatory progress o [Read more]